Log in to save to my catalogue

A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrec...

A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrec...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2115921791

A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial

About this item

Full title

A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial

Publisher

Singapore: Springer Singapore

Journal title

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019-05, Vol.22 (3), p.598-606

Language

English

Formats

Publication information

Publisher

Singapore: Springer Singapore

More information

Scope and Contents

Contents

Background
The prognosis of patients with gastric cancer with bulky node metastasis, linitis plastica (type 4), or large ulcero-invasive-type tumors (type 3) remains poor. We conducted a phase II study to evaluate the safety and efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 (DCS) for establishing a new treatment modalit...

Alternative Titles

Full title

A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2115921791

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2115921791

Other Identifiers

ISSN

1436-3291

E-ISSN

1436-3305

DOI

10.1007/s10120-018-0884-0

How to access this item